Cargando…

Diffuse midline glioma with H3 K27M-mutation in an 83-year-old woman

Diffuse midline gliomas harboring histone H3 K27M mutations are most commonly found in the brainstem of children. This mutation confers a WHO grade IV designation and is associated with a particularly poor prognosis. Although traditionally considered to be a disease of children and young adults, a n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Low, Justin Thomas, Wang, Shih-Hsiu, B Peters, Katherine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8162147/ https://www.ncbi.nlm.nih.gov/pubmed/33908265 http://dx.doi.org/10.2217/cns-2020-0030

Ejemplares similares

MRI comparative study of diffuse midline glioma, H3 K27-altered and glioma in the midline without H3 K27-altered
por: Zhao, Ji-ping, et al.
Publicado: (2022)

Fatal Postpartum Hemorrhage in Diffuse Midline Glioma with H3-K27M Mutation
por: Miyazaki, Takeshi, et al.
Publicado: (2019)

Radiotherapy and radio‐sensitization in H3 (K27M) ‐mutated diffuse midline gliomas
por: Liu, Chao, et al.
Publicado: (2023)

Mutations within FGFR1 are associated with superior outcome in a series of 83 diffuse midline gliomas with H3F3A K27M mutations
por: Schüller, Ulrich, et al.
Publicado: (2021)

Morphological Spectrum and Survival Analysis of Diffuse Midline Glioma With H3K27M Mutation
por: Hassan, Usman, et al.
Publicado: (2021)

Diffuse midline glioma H3K27M mutation in adult: A case report
por: Bhattarai, Ayush Mohan, et al.
Publicado: (2022)

Differences in the MRI Signature and ADC Values of Diffuse Midline Gliomas with H3 K27M Mutation Compared to Midline Glioblastomas
por: Raab, Peter, et al.
Publicado: (2022)

GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas
por: Majzner, Robbie G., et al.
Publicado: (2022)

DIPG-42. Diffuse midline gliomas, H3K27-altered as an interdisciplinary challenge
por: Kammler, Gertrud, et al.
Publicado: (2022)

A H3K27M-targeted vaccine in adults with diffuse midline glioma
por: Grassl, Niklas, et al.
Publicado: (2023)

Multimodal MR imaging signatures to identify brain diffuse midline gliomas with H3 K27M mutation
por: Su, Xiaorui, et al.
Publicado: (2021)

Exploring MRI Characteristics of Brain Diffuse Midline Gliomas With the H3 K27M Mutation Using Radiomics
por: Li, Qian, et al.
Publicado: (2021)

Spinal Cord Diffuse Midline Glioma With Histone H3 K27M Mutation in a Pediatric Patient
por: Cheng, Ran, et al.
Publicado: (2021)

CEREBELLAR DIFFUSE MIDLINE GLIOMA, H3K27M ALTERED IN A FIFTY-FIVE-YEAR-OLD PATIENT
por: Ibdah, Haleem, et al.
Publicado: (2023)

Absence of MGMT promoter methylation in diffuse midline glioma, H3 K27M-mutant
por: Banan, Rouzbeh, et al.
Publicado: (2017)

Current Murine Models and New Developments in H3K27M Diffuse Midline Gliomas
por: Welby, John P., et al.
Publicado: (2019)

Deep Learning for the Prediction of the Survival of Midline Diffuse Glioma with an H3K27M Alteration
por: Huang, Bowen, et al.
Publicado: (2023)

ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma
por: Jackson, Evangeline R., et al.
Publicado: (2023)

Diffuse non-midline glioma with H3F3A K27M mutation: a prognostic and treatment dilemma
por: López, Giselle, et al.
Publicado: (2017)

DIPG-78. REVERTANCE OF THE H3K27M MUTATION RESCUES CHROMATIN MARKS NECESSARY FOR ONCOGENESIS IN DIFFUSE MIDLINE GLIOMA
por: Nesvick, Cody, et al.
Publicado: (2020)

Diffuse Midline Gliomas With Histone H3 K27M Mutation in Adults and Children: A Retrospective Series of 164 Cases
por: Zheng, Linmao, et al.
Publicado: (2022)

Diffuse midline glioma with H3-K27M mutation: A rare case with GFAP-positive anucleate whorled patterns
por: Wang, Yi-Hua, et al.
Publicado: (2022)

Diffuse midline gliomas, H3 K27M-mutant are associated with less peritumoral edema and contrast enhancement in comparison to glioblastomas, H3 K27M-wildtype of midline structures
por: Banan, Rouzbeh, et al.
Publicado: (2021)

MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas
por: Abe, Hideaki, et al.
Publicado: (2020)

Exploiting Gangliosides for the Therapy of Ewing’s Sarcoma and H3K27M-Mutant Diffuse Midline Glioma
por: Wingerter, Arthur, et al.
Publicado: (2021)

DIPG-44. H3K27-altered diffuse midline gliomas with secondary driver molecular alterations
por: Gestrich, Catherine, et al.
Publicado: (2022)

A validated prognostic nomogram for patients with H3 K27M-mutant diffuse midline glioma
por: Peng, Youheng, et al.
Publicado: (2023)

Treatment Strategies in Diffuse Midline Gliomas With the H3K27M Mutation: The Role of Convection-Enhanced Delivery in Overcoming Anatomic Challenges
por: Himes, Benjamin T., et al.
Publicado: (2019)

H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2(+) patients with diffuse midline glioma
por: Immisch, Lena, et al.
Publicado: (2022)

Disseminated diffuse midline gliomas, H3K27-altered mimicking diffuse leptomeningeal glioneuronal tumors: a diagnostical challenge!
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2022)

Clinical, radiologic, and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adults
por: Schulte, Jessica D, et al.
Publicado: (2020)

New Developments in the Pathogenesis, Therapeutic Targeting, and Treatment of H3K27M-Mutant Diffuse Midline Glioma
por: Argersinger, Davis P., et al.
Publicado: (2021)

Case Report: Five Adult Cases of H3K27-Altered Diffuse Midline Glioma in the Spinal Cord
por: Gu, Quanquan, et al.
Publicado: (2021)

A rare case of adult diffuse midline glioma with H3 K27M mutant in the prepontine cistern
por: Chen, Xueling, et al.
Publicado: (2021)

STAT3 as a biologically relevant target in H3K27M-mutant diffuse midline glioma
por: Anderson, Jacob B., et al.
Publicado: (2023)

Differences in survival prognosticators between children and adults with H3K27M‐mutant diffuse midline glioma
por: Gong, Xuan, et al.
Publicado: (2023)

Histone H3 K27M-mediated regulation of cancer cell stemness and differentiation in diffuse midline glioma
por: Sharma, Monika, et al.
Publicado: (2023)

DIPG-51. ABDOMINAL METASTASES OF DIFFUSE MIDLINE GLIOMA, H3K27-ALTERED WITH A VENTRICULOPERITONEAL SHUNT
por: Lazow, Margot, et al.
Publicado: (2023)

Targeted therapy with anlotinib for a H3K27M mutation diffuse midline glioma patient with PDGFR-α mutation: a case report
por: Wang, Qiang, et al.
Publicado: (2021)

Incidence and clinicopathologic features of H3 K27M mutations in adults with radiographically-determined midline gliomas
por: Schreck, Karisa C., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_738mq05jql4jirieaqb69b4c1f